Orgenesis Inc
ORGS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.05M
Close$
$-0.83
240.4% downside
Current Fair Value
240.4% downsideOvervalued by 240.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.05 Million |
|---|---|
| Enterprise Value | $2.85 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.91 |
| Beta | 3.07 |
| Outstanding Shares | 47,152,290 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | -86.47% |
| Return on Invested Capital | -195.46% |
Valuation & Multiples
| P/E Ratio | -0.31 |
|---|---|
| PEG | 1.11 |
| Price to Sales | -0.59 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.21 |
| Enterprise Value to EBIT | -0.05 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-2.30
Average shareholder expectationRevenue Estimate
$3.30 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data